Amylyx Pharmaceuticals (AMLX) Stock Price
$3.3 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Amylyx Pharmaceuticals, AI stock picks, stock alerts and much more.
AMLX AI Stock Analysis
AI stock analysis for AMLX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Amylyx Pharmaceuticals (AMLX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Amylyx Pharmaceuticals (AMLX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Amylyx Pharmaceuticals (AMLX), currently trading at $3.3, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About AMLX
-
Amylyx Pharmaceuticals, Inc.
-
Symbol
AMLX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
282.8M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
AMLX Alternative Data
Web Traffic
Amylyx Pharmaceuticals receives an estimated 8512 monthly visitors to amylyx.com.
-
Web Traffic
8512
-
Change from Previous Month
29.2%
-
3 Month Change
19.2%
News Mentions
Amylyx Pharmaceuticals was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
Amylyx Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Amylyx Pharmaceuticals has 2,940 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.
-
Twitter Followers
2940
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
1.3%
Facebook Engagement
Amylyx Pharmaceuticals has engaged 25 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
25
-
Daily Change
8.7%
-
1 Month Change
0%
-
3 Month Change
316.7%
LinkedIn Followers
69,732 are following Amylyx Pharmaceuticals on LinkedIn, up by 0.6% over the last month.
-
LinkedIn Followers
69732
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
1.5%
Job Postings
Amylyx Pharmaceuticals has an estimated 4 open job postings, which is down -33.3% over the last month.
-
Job Postings
4
-
Daily Change
0%
-
1 Month Change
33.3%
-
3 Month Change
20%
LinkedIn Employees
According to LinkedIn, Amylyx Pharmaceuticals has 164 employees, down by -9.4% over the last month.
-
LinkedIn Employees
164
-
Daily Change
0.6%
-
1 Month Change
9.4%
-
3 Month Change
18.4%
Business Outlook
-
Business Outlook
52
-
Change from Previous Month
10.3%
-
3 Month Change
0%
-
YoY Change
0%
AMLX Financials
AMLX Key Metrics
-
Total Revenue
$416K
-
Net Income
-$72.7M
-
Earnings per Share
-$1.07
-
Free cash flow
-$41.6M
-
EBITDA
-$75.7M
-
EBITDA Ratio
-181.877
-
Total Assets
$250.7M
AMLX 2-year Revenue & Income
AMLX 2-year Free Cash Flow
AMLX Technicals
AMLX SMA
AMLX RSI
FAQ
What's the current price of Amylyx Pharmaceuticals (AMLX) Stock?
The price of an Amylyx Pharmaceuticals (AMLX) share is $3.3.
What's the market cap of Amylyx Pharmaceuticals?
The current market cap of Amylyx Pharmaceuticals is 282.8M.
Should I buy or sell AMLX?
Amylyx Pharmaceuticals exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Amylyx Pharmaceuticals a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Amylyx Pharmaceuticals stock. There are several bearish signals and market challenges that could negatively impact Amylyx Pharmaceuticals' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Amylyx Pharmaceuticals (AMLX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Amylyx Pharmaceuticals stock right now, as the outlook appears bearish.
What are some stocks similar to Amylyx Pharmaceuticals (AMLX) that investors often compare it to?
Amylyx Pharmaceuticals (AMLX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Amylyx Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Amylyx Pharmaceuticals' stock price to be around $3.1 in 2026. Starting from the current price of $3.3, this represents a 6% change in price, indicating a bearish outlook for the stock.
How to buy Amylyx Pharmaceuticals (AMLX) Stock?
Amylyx Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Amylyx Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.